CARE Ratings appoints Sanjay Agarwal as Chief Risk Officer

0 min read     Updated on 02 Jul 2026, 05:40 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

CARE Ratings has appointed Mr. Sanjay Agarwal as its Chief Risk Officer effective August 1, 2026. A qualified Chartered Accountant with over 30 years of experience, Mr. Agarwal specializes in risk management and credit analysis. He has been with the company for 16 years and currently serves as Senior Director.

powered bylight_fuzz_icon
44432285

*this image is generated using AI for illustrative purposes only.

care ratings has appointed Mr. Sanjay Agarwal as its Chief Risk Officer effective August 1, 2026. The appointment strengthens the company's risk management framework, leveraging his extensive experience in the financial services sector.

Mr. Agarwal is a qualified Chartered Accountant with over 30 years of experience, specializing in risk management, credit analysis, project financing, and financial research. He has been associated with the company for the past 16 years and currently holds the position of Senior Director.

Details of Appointment

The disclosure was made to the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The appointment details were submitted to BSE Limited and The National Stock Exchange of India Limited.

Particulars Details
Name Mr. Sanjay Agarwal
Designation Chief Risk Officer
Effective Date August 1, 2026
Experience Over 30 years in financial services
Current Role Senior Director

The company stated that Mr. Agarwal possesses extensive industry knowledge, analytical rigor, and a strategic perspective, which will be instrumental in his new role.

Historical Stock Returns for CARE Ratings

1 Day5 Days1 Month6 Months1 Year5 Years
+0.61%-0.61%+4.21%+3.59%-8.63%+140.56%

How will Mr. Agarwal's appointment influence CARE Ratings' risk assessment methodologies in the near future?

What strategic initiatives might the company undertake under his leadership to enhance its risk management framework?

Could this appointment lead to changes in the company's credit rating policies or sector-specific exposures?

CARE Ratings reschedules analyst meet to June 29

0 min read     Updated on 26 Jun 2026, 01:58 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

CARE Ratings has rescheduled its virtual analyst and institutional investor meet with Millingtonia Capital from June 25, 2026, to June 29, 2026, at 12:00 PM IST due to exigencies. The meeting will focus on the company's performance and outlook based on publicly available information, and no unpublished price sensitive information will be shared. The investor presentation for Q4 and FY26 is available on the company's website.

powered bylight_fuzz_icon
43657057

*this image is generated using AI for illustrative purposes only.

CARE Ratings has rescheduled its virtual analyst and institutional investor meet with Millingtonia Capital to June 29, 2026, at 12:00 PM IST due to exigencies. The meeting, originally set for June 25, 2026, at 02:00 PM IST, will discuss the company's performance and outlook based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.

The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company noted that the schedule may undergo changes due to exigencies on the part of the participants or the company.

The investor presentation covering Q4 and FY26 has been made available on the official website of CARE Ratings Limited. Manoj Kumar CV, Company Secretary & Compliance Officer, signed the intimation on June 25, 2026.

Meeting Schedule

Sr.No. Fund/Research House Date of Meeting/Event Time Type of Event/Meeting
1 Millingtonia Capital 29 June 2026 12:00 PM Virtual

Historical Stock Returns for CARE Ratings

1 Day5 Days1 Month6 Months1 Year5 Years
+0.61%-0.61%+4.21%+3.59%-8.63%+140.56%

What specific exigencies led to the rescheduling of the meeting with Millingtonia Capital?

How might the delay impact investor sentiment or market perception of CARE Ratings?

Will the rescheduling affect the timing or content of the Q4 and FY26 investor presentation?

More News on CARE Ratings

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-8.63%